deltatrials
Completed OBSERVATIONAL NCT02434484

Symbenda Post-Marketing Surveillance (PMS)

Post-Marketing Surveillance of Symbenda Injection (Bendamustine Hydrochloride) in Korean Patients

Sponsor: Eisai Korea Inc.

Conditions Lymphocytic Leukemia Lymphoma, Non-Hodgkin Multiple Myeloma
Updated 15 times since 2017 Last updated: Jan 25, 2021 Started: Jul 4, 2018 Primary completion: Mar 20, 2020 Completion: Mar 20, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02434484, this observational or N/A phase trial focuses on Lymphocytic Leukemia and Lymphoma, Non-Hodgkin and remains completed. Sponsored by Eisai Korea Inc., it has been updated 15 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Apr 2018 · 11 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Jan 2020 · 15 months · monthly snapshot~Jan 2020 – ~Apr 2020 · 3 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jul 2024 · 41 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Feb 2021 — Jul 2024 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  5. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting

▶ Show 10 earlier versions

  1. May 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  2. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  3. Jan 2020 — Apr 2020 [monthly]

    Recruiting

  4. Oct 2018 — Jan 2020 [monthly]

    Recruiting

  5. Sep 2018 — Oct 2018 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  6. Jun 2018 — Sep 2018 [monthly]

    Not Yet Recruiting

  7. Apr 2018 — Jun 2018 [monthly]

    Not Yet Recruiting

    Phase: NA → None

  8. May 2017 — Apr 2018 [monthly]

    Not Yet Recruiting NA

  9. Feb 2017 — May 2017 [monthly]

    Not Yet Recruiting NA

  10. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eisai Korea Inc.
Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations